Lumeda Inc.
PrivateLast Round
Series A
Apr 8, 2021
Total Funding Raised
$5.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lumeda Inc. is a medical technology company that develops a photodynamic therapy (PDT) platform, DigiLum™, as an adjuvant treatment for patients with non-small cell lung cancer (NSCLC) and other thoracic malignancies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumeda Inc. Comparables
Compare Lumeda Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemerion Therapeutics | 78% | |
| Modulight Oyj | 74% | |
| Illumacell Inc. | 71% | |
Lumeda Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 8, 2021 | ||||
| Seed | Jun 4, 2020 |
Lumeda Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 8, 800% of headcount.
Lumeda Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumeda Inc.'s valuation, stock price, and market status.